• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Clin Cases . Clinical diagnosis of severe COVID-19: A derivation and validation of a prediction rule

tetano

Editor, Senior Moderator
World J Clin Cases


. 2021 May 6;9(13):2994-3007.
doi: 10.12998/wjcc.v9.i13.2994.
Clinical diagnosis of severe COVID-19: A derivation and validation of a prediction rule


Ming Tang[SUP] 1 [/SUP], Xia-Xia Yu[SUP] 2 [/SUP], Jia Huang[SUP] 1 [/SUP], Jun-Ling Gao[SUP] 3 [/SUP], Fu-Lan Cen[SUP] 1 [/SUP], Qi Xiao[SUP] 1 [/SUP], Shou-Zhi Fu[SUP] 4 [/SUP], Yang Yang[SUP] 5 [/SUP], Bo Xiong[SUP] 6 [/SUP], Yong-Jun Pan[SUP] 7 [/SUP], Ying-Xia Liu[SUP] 1 [/SUP], Yong-Wen Feng[SUP] 8 [/SUP], Jin-Xiu Li[SUP] 9 [/SUP], Yong Liu[SUP] 10 [/SUP]



Affiliations

Abstract

Background: The widespread coronavirus disease 2019 (COVID-19) has led to high morbidity and mortality. Therefore, early risk identification of critically ill patients remains crucial.
Aim: To develop predictive rules at the time of admission to identify COVID-19 patients who might require intensive care unit (ICU) care.
Methods: This retrospective study included a total of 361 patients with confirmed COVID-19 by reverse transcription-polymerase chain reaction between January 19, 2020, and March 14, 2020 in Shenzhen Third People's Hospital. Multivariate logistic regression was applied to develop the predictive model. The performance of the predictive model was externally validated and evaluated based on a dataset involving 126 patients from the Wuhan Asia General Hospital between December 2019 and March 2020, by area under the receiver operating curve (AUROC), goodness-of-fit and the performance matrix including the sensitivity, specificity, and precision. A nomogram was also used to visualize the model.
Results: Among the patients in the derivation and validation datasets, 38 and 9 participants (10.5% and 2.54%, respectively) developed severe COVID-19, respectively. In univariate analysis, 21 parameters such as age, sex (male), smoker, body mass index (BMI), time from onset to admission (> 5 d), asthenia, dry cough, expectoration, shortness of breath, asthenia, and Rox index < 18 (pulse oxygen saturation, SpO[SUB]2[/SUB])/(FiO[SUB]2[/SUB] ? respiratory rate, RR) showed positive correlations with severe COVID-19. In multivariate logistic regression analysis, only six parameters including BMI [odds ratio (OR) 3.939; 95% confidence interval (CI): 1.409-11.015; P = 0.009], time from onset to admission (? 5 d) (OR 7.107; 95%CI: 1.449-34.849; P = 0.016), fever (OR 6.794; 95%CI: 1.401-32.951; P = 0.017), Charlson index (OR 2.917; 95%CI: 1.279-6.654; P = 0.011), PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio (OR 17.570; 95%CI: 1.117-276.383; P = 0.041), and neutrophil/lymphocyte ratio (OR 3.574; 95%CI: 1.048-12.191; P = 0.042) were found to be independent predictors of COVID-19. These factors were found to be significant risk factors for severe patients confirmed with COVID-19. The AUROC was 0.941 (95%CI: 0.901-0.981) and 0.936 (95%CI: 0.886-0.987) in both datasets. The calibration properties were good.
Conclusion: The proposed predictive model had great potential in severity prediction of COVID-19 in the ICU. It assisted the ICU clinicians in making timely decisions for the target population.

Keywords: COVID-19; Clinical decision rules; Communicable diseases; Nomograms; Prognosis.
 
Back
Top Bottom